A novel robot-assisted method for implanting intracortical sensorimotor devices for brain-computer interface studies

J Neurosurg 142:1280–1288, 2025

A novel robot-assisted method for implanting intracortical microelectrode arrays in brain-computer interface studies was successfully demonstrated in a tetraplegic participant. The technique ensured precise placement, facilitating high-quality signal communication for motor control and sensory feedback, with promising implications for restoring upper-limb function.

• A novel robot-assisted method for implanting intracortical microelectrode arrays in brain-computer interface (BCI) studies is presented, focusing on surgical techniques and challenges.

• The technique was applied in a 31-year-old male with tetraplegia, enabling 2D control of a virtual arm with high success rates and maintaining recording quality over time.

• The robotic neurosurgery technique provides high accuracy and time efficiency, reducing human error and surgeon burden in repetitive procedures.

Preoperative imaging and robotic systems were used for precise planning and execution of array implantations, ensuring minimal cortical damage and high signal quality.

• The study demonstrated that robotic neurosurgery could be successfully translated into BCI device implantation, aiming to restore upper-limb function.

• Future challenges include refining insertion methods, increasing automation, and addressing intraoperative adjustments for microvessels.

• The study was conducted under an investigational device exemption from the US Food and Drug Administration and received institutional review board approval.

Intraoperative optical imaging for functional mapping

Intraoperative optical imaging for functional mapping

J Neurosurg 119:853–863, 2013

Intraoperative optical imaging (IOI) is an experimental technique used for visualizing functional brain areas after surgical exposure of the cerebral cortex. This technique identifies areas of local changes in blood volume and oxygenation caused by stimulation of specific brain functions. The authors describe a new IOI method, including innovative data analysis, that can facilitate intraoperative functional imaging on a routine basis. To evaluate the reliability and validity of this approach, they used the new IOI method to demonstrate visualization of the median nerve area of the somatosensory cortex.

Methods. In 41 patients with tumor lesions adjacent to the postcentral gyrus, lesions were surgically removed by using IOI during stimulation of the contralateral median nerve. Optical properties of the cortical tissue were measured with a sensitive camera system connected to a surgical microscope. Imaging was performed by using 9 cycles of alternating prolonged stimulation and rest periods of 30 seconds. Intraoperative optical imaging was based on blood volume changes detected by using a filter at an isosbestic wavelength (delta = 568 nm). A spectral analysis algorithm was used to improve computation of the activity maps. Movement artifacts were compensated for by an elastic registration algorithm. For validation, intraoperative conduction of the phase reversal over the central sulcus and postoperative evaluation of the craniotomy site were used.

Results. The new method and analysis enabled significant differentiation (p < 0.005) between functional and nonfunctional tissue. The identification and visualization of functionally intact somatosensory cortex was highly reliable; sensitivity was 94.4% and specificity was almost 100%. The surgeon was provided with a 2D high-resolution activity map within 12 minutes. No method-related side effects occurred in any of the 41 patients.

Conclusions. The authors’ new approach makes IOI a contact-free and label-free optical technique that can be used safely in a routine clinical setup. Intraoperative optical imaging can be used as an alternative to other methods for the identification of sensory cortex areas and offers the added benefit of a high-resolution map of functional activity. It has great potential for visualizing and monitoring additional specific functional brain areas such as the visual, motor, and speech cortex. A prospective national multicenter clinical trial is currently being planned.